0001415889-24-014147.txt : 20240522
0001415889-24-014147.hdr.sgml : 20240522
20240522183440
ACCESSION NUMBER: 0001415889-24-014147
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240520
FILED AS OF DATE: 20240522
DATE AS OF CHANGE: 20240522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Williams Paul Christopher
CENTRAL INDEX KEY: 0001951234
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40632
FILM NUMBER: 24974742
MAIL ADDRESS:
STREET 1: C/O CYTEK BIOSCIENCES, INC.
STREET 2: 47215 LAKEVIEW BOULEVARD
CITY: FREMONT
STATE: CA
ZIP: 94538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytek Biosciences, Inc.
CENTRAL INDEX KEY: 0001831915
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 472547526
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47215 LAKEVIEW BOULEVARD
CITY: FREMONT
STATE: CA
ZIP: 94538
BUSINESS PHONE: (877) 922-9835
MAIL ADDRESS:
STREET 1: 47215 LAKEVIEW BOULEVARD
CITY: FREMONT
STATE: CA
ZIP: 94538
FORMER COMPANY:
FORMER CONFORMED NAME: Cytek BioSciences, Inc.
DATE OF NAME CHANGE: 20201110
4
1
form4-05222024_100534.xml
X0508
4
2024-05-20
0001831915
Cytek Biosciences, Inc.
CTKB
0001951234
Williams Paul Christopher
C/O CYTEK BIOSCIENCES, INC.
47215 LAKEVIEW BOULEVARD
FREMONT
CA
94538
false
true
false
false
CHIEF OPERATING OFFICER
0
Common Stock
2024-05-20
4
M
0
1006
A
6323
D
Common Stock
2024-05-20
4
F
0
392
5.96
D
5931
D
Common Stock
2024-05-20
4
M
0
613
A
6544
D
Common Stock
2024-05-20
4
F
0
239
5.96
D
6305
D
Common Stock
2024-05-20
4
M
0
5893
A
12198
D
Common Stock
2024-05-20
4
F
0
2296
5.96
D
9902
D
Restricted Stock Units
2024-05-20
4
M
0
1006
0
D
Common Stock
1006
10069
D
Restricted Stock Units
2024-05-20
4
M
0
613
0
D
Common Stock
613
10433
D
Restricted Stock Units
2024-05-20
4
M
0
5893
0
D
Common Stock
5893
135549
D
Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
Represents the number of shares withheld by and surrendered to the Issuer on May 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and 3/48 of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on February 18, May 18, August 18 and November 18.
The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.
The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2025 and each March 10 thereafter.
/s/ Valerie Barnett, Attorney-in-Fact
2024-05-22